Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001999371-26-004388
Filing Date
2026-02-26
Accepted
2026-02-26 07:03:05
Documents
1
Period of Report
2026-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 - SAENGER saenger-form4_022626.html 4  
1 FORM 4 - SAENGER saenger-form4_022626.xml 4 6390
  Complete submission text file 0001999371-26-004388.txt   7992
Mailing Address 200 CONNELL DRIVE, SUITE 3100 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE, SUITE 3100 BERKELEY HEIGHTS NJ 07922 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
SAENGER BRADLEY (Reporting) CIK: 0001668150 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 26681650